A Melatonin Preparation with a Pulsatile Liberation Pattern: A New Form of Melatonin in Replacement Therapy

NeuroSignals

Volumn 8, Issue 1-2, 1999, Pages 96-104

  Hoffmann, A ^a   Farker, K ^a   Dittgen, M ^b   Hoffmann, H ^b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Melatonin; Pharmacokinetics; Pulsatile liberation

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CROSSOVER PROCEDURE; DOG; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PULSATILE DRUG RELEASE; SENESCENCE; SLEEP DISORDER;

ADMINISTRATION, ORAL; ANIMALS; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOGS; HUMANS; MALE; MELATONIN;

EID: 0033037291     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014576     Document Type: Article

References (38)

1. Reiter RJ: The melatonin rhythm: Both a clock a calender. Experientia 1993;49:654-664.
2. Arendt J: Melatonin and the mammalian pineal gland. London, Chapman & Hall, 1995, pp 161-200.
3. Iguchi H, Kato K, Ibayashi H: Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J Clin Endocrinol Me-tab 1982;55:27-29.
4. Waldhauser F, Weiszenbacher G, Tatzer E, Gisinger B, Waldhauser M, Schemper M, Frisch H: Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 1988;66:648-652.
5. Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, Herer P, Tzischinsky O, Lavie P: Sleep disorders and melatonin rhythms in elderly people. Br Med J 1994;309:167.
6. Arendt J, Deacon S: Treatment of circadian rhythm disorders-melatonin. Chronobiol Int 1997; 14:185-204.
7. Sack RL, Lewy AJ, Hughes RJ: Use of melatonin for sleep and circadian rhythm disorder. Ann Med 1998;30: 115-121.
8. Brown GM: Melatonin in psychiatric and sleep disorders. CNS Drugs 1995;3:209-226.
9. Zhdanova IV, Wurtman RJ, Mora-bito C, Piotrovska VR, Lynch HJ: Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. Sleep 1996;19:423-431.
10. Zhadanova IV, Lynch HJ, Wurt-mann RJ: Melatonin: A sleep-promoting hormone. Sleep 1997;20: 899-907.
11. Garfinkel D, Laudon M, Nof D, Zis-apel N: Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995;346: 541-544.
12. Garfinkel D, Zisapel N: The use of melatonin for sleep. Nutrition 1998; 14:53-55.
13. Petrie K, Dawson AG, Thomson L, Brook R: A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol Psychiatry 1993;33:526-530.
14. Dawson D, Encel N, Lushington K: Improving adaption to simulated night shift: Timed exposure to bright light versus daytime melatonin administration. Sleep 1995; 18: 11-21.
15. Van Reeth O: Sleep and circadian disturbances in shift work: Strategies for their management. Horm Res 1998;49:158-162.
16. Thalen BE, Kjellman BF, Morkrid L, Wetterberg L: Melatonin in light treatment of patients with seasonal and nonseasonal depression. Acta Psychiatr Scand 1995;92:274-284.
17. Benes L, Brun J, Claustrat B, DeGrande G, Ducloux N, Geoffriau M, Horriere F, Karsenty H, Lagain D; in Touitou Y, Arendt J, Pevet P (eds): Melatonin and the Pineal Gland. From Basic Science to Clinical Application. Amsterdam, Elsevier Science Publishers, 1993, pp 347-350.
18. Lewy AJ, Sack RL, Parrott KA, Ayres JW: Sustained release oral compositions containing melatonin. WO 95/03043 US (1994).
19. Zisapel N: EP 0 518 468 A1.
20. Lee B-J, Min G-H: Preparation and release characteristics of polymer-reinforced and coated alginate beads. Arch Pharm Res 1995;18: 183-188.
21. Lee B-J, Parrott KA, Ayres JW, Sack RL: Design and evaluation of an oral controlled release delivery system for melatonin in human subjects. Int J Pharm 1995;124:119-127.
22. Lee B-J, Min G-H: Oral controlled release of melatonin using polymer-reinforced coated alginate beads. Int J Pharm 1996;144:37-46.
23. Aldhous M, Franey C, Wright J, Ar-endt J: Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol 1985; 19:517-521.
24. Lee B-J, Parrott KA, Ayres JW, Sack RL: Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res Commun Mol Pathol Pharmacol 1994;85:337-346.
25. Dittgen M, Hoffmann H: New dosage form for pulsatile delivery of melatonin: Development and testing in animal and human subjects. Aging Male 1998;1:141-148.
26. Hoffmann H, Dittgen M, Hoffmann A, Bartsch C, Breitbarth H, Timpe C, Farker K, Schmidt U, Mellinger U, Zimmermann H, Graser T, Oet-tel M: Evaluation of an oral pulsatile delivery system for melatonin in humans. Pharmazie 1998;7:462-466.
27. Fraser S, Cowen P, Franklin M, Fra-ney C, Arendt J: Direct radioimmunoassay for melatonin in plasma. J Clin Chem 1983;29:396-397.
28. Aldhous M, Arendt J: Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann Clin Biochem 1988;25:298-303.
29. Di W, Kadva A, Johnston A, Silman R: Variable bioavailability of oral melatonin. N Engl J Med 1997;333: 1028-1029.
30. Mallo C, Zaidan R, Galy G, Ver-meulen E, Brun J, Chazot G, Claus-trat B: Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur J Clin Pharmacol 1990;38:297-301.
31. Nowak R, McMillen IC, Redman J, Short RV: The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxy-melatonin sulphate excretion rates: Two non-invasive techniques for monitoring human circadian rhyth-micity. Clin Endocrinol (Oxf) 1987; 27:445-452.
32. Yeleswaram K, McLaughlin LG, Knipe JO, Schabdach D: Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal studies and clinical implications. J Pineal Res 1997;22:45-51.
33. Junginger HE: In Gurny R, Jungin-ger HE, Peppas NA (eds): Pulsatile Drug Delivery: Current Applications and Future Trends. Stuttgart, Wissenschaftliche Verlagsgesell-schaft, 1993, pp 113-136.
34. Dittgen M: DE 44 43 175 A1.
35. Chase JE, Gidal BE: Melatonin: Therapeutic use in sleep disorders. Ann Pharmacother 1997;31: 1218-1226.
36. Sedgwick PM: Disorders of the sleep-wake cycle in adults. Postgrad Med J 1998;74:134-138.
37. Dagan Y, Zisapel N, Nof D, Laudon M, Atsmon J: Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: A case report. Eur Neuropsychophar-macol 1997;7:157-160.
38. Defrance R, Quera Salva MA: Therapeutic application of melatonin and related compounds. Horm Res 1998;49:142-146.